Kyp Sirinakis

Co-Founder & Managing Partner, Epidarex Capital

Kyp Sirinakis has more than 25 years of experience in creating and growing companies both as an early-stage venture investor and a senior executive in various technology and life science companies. Based in Maryland, Kyp is the Co-founder and Managing Director of Epidarex Capital, a transatlantic venture capital firm which invests in early stage life science and health technology companies in under-ventured markets within the US and Europe.  Epidarex’s portfolio has a strong emphasis on university related spin-outs.  Prior to launching Epidarex, she was part of the senior management team of MASA Life Science Ventures, an early stage life science venture fund.  Kyp was the Founder and Managing Director of LLC, a fund investing in startup technology and healthcare companies in the Washington DC metro region.  She was the CFO of Oncologix, a venture-backed, early-stage biotechnology company based in Gaithersburg which was subsequently sold to Antigenics, Inc. 

Kyp serves on the Board of the Tech Council of Maryland, the Sid Martin Advisory Council, and the Investment Advisory Committees for Virginia’s Center for Innovative Technology BioLife Fund, the Momentum Fund (University of Maryland System) and the Ivy Foundation at the University of Virginia.  Kyp has held numerous directorships of start-up companies throughout her career and is currently on the Board of Harpoon Medical, Confluence Life Science, Sirakoss Ltd, Nodthera Ltd. , IGEM Therapeutics Ltd. and Eternygen GmbH.  She is a graduate of Boston College’s School of Management Honors Program.